nach oben

Erschienen in:

01.08.2010 | Original Communication

Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2

verfasst von: Vincenzo Romeo, E. Pegoraro, C. Ferrati, F. Squarzanti, G. Sorarù, A. Palmieri, P. Zucchetta, L. Antunovic, E. Bonifazi, G. Novelli, C. P. Trevisan, M. Ermani, R. Manara, C. Angelini

Erschienen in: Journal of Neurology | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to determine the degree of brain involvement in a cohort of myotonic dystrophy type 1 and type 2 (DM1, DM2) patients by brain studies and functional tests and to compare the results of the two groups. DM1, DM2 are multisystemic disorders due to polynucleotide expansions. Previous studies on brain involvement by neuroimaging and functional methods have led to contradictory results. Fifty molecularly defined DM1 patients and 14 DM2 patients, were recruited for the study. Age at recruitment, age at disease onset, disease duration and educational level were recorded. Neuromuscular assessment was done by MIRS. An extensive neuropsychological battery was performed in 48/50 DM1 and in a control group of 44 healthy matched subjects. Forty six of 50 DM1 and 12/14 DM2 underwent brain MRI; 21/50 DM1 and 9/14 DM2 underwent brain perfusion SPECT, with semiquantitative analysis of the results. MRI images were classified by ARWMC (age-related white matter changes) score, in order to quantify recurrence, localization and patterns of distribution of white matter hyperintense lesions (WMHLs) in our two cohorts. MRI results were matched to SPECT and to neuropsychological results. Thirty-seven of 46 DM1 and 10/12 DM2 had abnormal MRI imaging, showing scattered supratentorial, bilateral, symmetrical focal or diffuse WMHLs. A typical temporo-insular diffuse subcortical pattern was seen in DM1 subjects only, with no correlation with cognitive involvement. Major cognitive involvement was seen in the case of diffuse frontal lesions. A relationship with CTG expansion size was documented for DM1 subjects. SPECT showed minimal hypoperfusion in the posterior cortex planes in DM1 and, to a lesser extent, in DM2. Very mild degrees of involvement in the DM2 cohort were seen. Neuroimaging and functional investigations confirmed a more severe involvement of the brain in DM1 compared to DM2. A temporo-insular diffuse lesional pattern, specific for DM1, was found on MRI. This confirms greater expansion size as a risk factor for more extensive brain involvement in DM1.

Nur mit Berechtigung zugänglich

Abe K, Fujimura H, Toyooka K, Yorifuji S, Nishikawa Y, Hazama T, Yanagihara T (1994) Involvement of the central nervous system in myotonic dystrophy. J Neurol Sci 127:179–185CrossRefPubMed

Annane D, Fiorelli M, Mazoyer B, Pappata S, Eymard B, Radvanyi H, Junien C, Fardeau M, Merlet P, Gajdos P, Syrota A, Sansom Y, Duboc D (1998) Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon. Neuromusc Disord 8:39–45CrossRefPubMed

Antonini G, Mainero C, Romano A, Giubilei F, Ceschin V, Gragnani F, Morino S, Fiorelli M, Soscia F, Di Pasquale A, Caramia F (2004) Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry 75:1611–1613CrossRefPubMed

Bachmann G, Damian MS, Koch M, Schilling G, Fach B, Stöppler S (1996) The clinical and genetic correlates of MRI findings in myotonic dystrophy. Neuroradiology 38:629–635CrossRefPubMed

Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799–808CrossRefPubMed

Burgess PW, Gilbert SJ, Dumontheil I (2007) Function and localization within rostral prefrontal cortex (area 10). Philos Trans R Soc Lond B Biol Sci 362:887–899CrossRefPubMed

Carter CS, van Veen V (2007) Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci 7:367–379CrossRefPubMed

Censori B, Provinciali L, Danni M, Chiaramoni L, Maricotti M, Foschi N, Del Pesce M, Salvolini U (1994) Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions. Acta Neurol Scand 90:211–217CrossRefPubMed

Chang L, Anderson T, Migneco OA, Boone K, Mehringer CM, Villanueva-Meyer J, Berman N, Mena I (1993) Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 50:917–923PubMed

10.

Chang L, Ernst T, Osborn D, Seltzer W, Leonido-Yee M, Poland RE (1998) Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 55:291–293CrossRef

11.

Charles DP, Browning PG, Gaffan D (2004) Entorhinal cortex contributes to object-in-place scene memory. Eur J Neurosci 20:3157–3164CrossRefPubMed

12.

Damian MS, Bachmann G, Koch MC, Schilling G, Stöppler S, Dorndorf W (1994) Brain disease and molecular analysis in myotonic dystrophy. Neuroreport 5:2549–2552CrossRefPubMed

13.

Damian MS, Schilling G, Bachmann G, Simon C, Stöppler S, Dorndorf W (1994) White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand 90:430–436CrossRefPubMed

14.

Day JW, Ranum LP (2005) RNA pathogenesis of the myotonic dystrophies. Neuromusc Disord 15:5–16CrossRefPubMed

15.

Di Costanzo A, Di Salle F, Santoro L, Bonavita V, Tedeschi G (2002) Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study. Neuromusc Disord 12:476–483CrossRefPubMed

16.

Di Costanzo A, Di Salle F, Santoro L, Bonavita V, Tedeschi G (2001) Dilated Virchow-Robin spaces in Myotonic Dystrophy: frequency, extent and significance. Eur Neurol 46:131–139CrossRefPubMed

17.

Di Costanzo A, Di Salle F, Santoro L, Bonavita V, Tedeschi G (2001) T2 relaxometry of brain in myotonic dystrophy. Neuroradiology 43:198–204CrossRefPubMed

18.

Di Costanzo A, Di Salle F, Santoro L, Tessitore A, Bonavita V, Tedeschi G (2002) Pattern and significance of white matter abnormalities in myotonic dystrophy type 1: an MRI study. J Neurol 249:1175–1182CrossRefPubMed

19.

Di Costanzo A, Santoro L, de Cristofaro M, Manganelli F, Di Salle F, Tedeschi G (2008) Familial aggregation of white matter lesions in myotonic dystrophy type 1. Neuromusc Disord 18:299–305CrossRefPubMed

20.

Fiorelli M, Duboc D, Mazoyer BM, Blin J, Eymard B, Fardeau M, Samson Y (1992) Decreased cerebral glucose utilization in myotonic dystrophy. Neurology 42:91–94PubMed

21.

Fukuda H, Horiguchi J, Ono C, Ohshita T, Takaba J, Ito K (2005) Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 46:104–109CrossRefPubMed

22.

Giorgio A, Dotti MT, Battaglini M, Marino S, Mortilla M, Stromillo ML, Bramanti P, Orrico A, Federico A, De Stefano N (2006) Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities. J Neurol 253:1471–1477CrossRefPubMed

23.

Glantz RH, Wright RB, Huckman MS, Garron DC, Siegel IM (1988) Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch Neurol 45:36–37PubMed

24.

Harris IM, Egan GF, Sonkkila C, Tochon-Danguy HJ, Paxinos G, Watson JD (2000) Selective right parietal lobe activation during mental rotation: a parametric PET study. Brain 123:65–73CrossRefPubMed

25.

Hashimoto T, Tayama M, Miyazaki M, Murakawa K, Kawai H, Nishitani H, Kuroda Y (1995) Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain. Brain Dev 17:24–27CrossRefPubMed

26.

Hashimoto T, Tayama M, Miyazaki M, Murakawa K, Kawai H, Nishitani H, Kuroda Y (1995) Neuroimaging study of myotonic dystrophy. II. MRI measurements of the brain. Brain Dev 17:24–27CrossRefPubMed

27.

Huber SJ, Kissel JT, Shuttleworth EC, Chakeres DW, Clapp LE, Brogan MA (1989) Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol 46:536–540PubMed

28.

Hund E, Jansen O, Koch MC, Ricker K, Fogel W, Niedermaier N, Otto M, Kuhn E, Meinck HM (1997) Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology 48:33–37PubMed

29.

Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG (2003) Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 348:73–76CrossRefPubMed

30.

Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schröder R (2004) Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 251:710–714CrossRefPubMed

31.

Kuo HC, Hsiao KM, Chen CJ, Hsieh YC, Huang CC (2005) Brain magnetic resonance image changes in a family with congenital and classic myotonic dystrophy. Brain Dev 27:291–296CrossRefPubMed

32.

Kuo HC, Hsieh YC, Wang HM, Chuang WL, Huang CC (2008) Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1. Acta Neurol Scand 117:101–107PubMed

33.

Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864–867CrossRefPubMed

34.

Lloyd D (2000) Terra cognita: from functional neuroimaging to the map of the mind. Brain and Mind. 1:1–24CrossRef

35.

Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE (1995) Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 36:1141–1149PubMed

36.

Marklund P, Fransson P, Cabeza R, Petersson KM, Ingvar M, Nyberg L (2007) Sustained and transient neural modulations in prefrontal cortex related to declarative long-term memory, working memory, and attention. Cortex 43:22–37CrossRefPubMed

37.

Martinello F, Piazza A, Pastorello E, Angelini C, Trevisan CP (1999) Clinical and neuroimaging study of central nervous system in congenital myotonic dystrophy. J Neurol 246:186–192CrossRefPubMed

38.

Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56:336–340PubMed

39.

Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, Fazio F, Thornton CA, Moxley RT (1999) Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 53:1042–1050PubMed

40.

Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromusc Disord 13:813–821CrossRefPubMed

41.

Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36:294–306CrossRefPubMed

42.

Miaux Y, Chiras J, Eymard B, Lauriot-Prevost MC, Radvanyi H, Martin-Duverneuil N, Delaporte C (1997) Cranial MRI findings in myotonic dystrophy. Neuroradiology 39:166–170CrossRefPubMed

43.

Mielke R, Herholz K, Fink G, Ritter D, Heiss WD (1993) Positron emission tomography in myotonic dystrophy. Psychiatry Res 50:93–99CrossRefPubMed

44.

Noulhiane M, Piolino P, Hasboun D, Clemenceau S, Baulac M, Samson S (2007) Autobiographical memory after temporal lobe resection: neuropsychological and MRI volumetric findings. Brain 130:3184–3199CrossRefPubMed

45.

Ogata A, Terae S, Fujita M, Tashiro K (1998) Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study. Neuroradiology 40:411–415CrossRefPubMed

46.

Okuda J, Fujii T, Ohtake H, Tsukiura T, Yamadori A, Frith CD, Burgess PW (2007) Differential involvement of regions of rostral prefrontal cortex (Brodmann area 10) in time- and event-based prospective memory. Int J Psychophysiol 64:233–246CrossRefPubMed

47.

Ota M, Sato N, Ohya Y, Aoki Y, Mizukami K, Mori T, Asada T (2006) Relationship between diffusion tensor imaging and brain morphology in patients with myotonic dystrophy. Neurosci Lett 407:234–239CrossRefPubMed

48.

Ranganath C, Johnson MK, D’Esposito M (2003) Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 41:378–389CrossRefPubMed

49.

Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW (1998) Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19:196–198CrossRefPubMed

50.

Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Otto M, Heine R, Moxley RT 3rd (1994) Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44:1448–1452PubMed

51.

Siciliano G, Manca M, Gennarelli M, Angelini C, Rocchi A, Iudice A, Miorin M, Mostacciuolo M (2001) Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. Clin Genet 59:344–349CrossRefPubMed

52.

Sinforiani E, Sandrini G, Martelli A, Mauri M, Uggetti C, Bono G, Nappi G (1991) Cognitive and neuroradiological findings in myotonic dystrophy. Funct Neurol 6:377–384PubMed

53.

The International Myotonic Dystrophy Consortium (IDMC) (2000) New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 54:1218–1221

54.

Thornton CA, Griggs RC, Moxley RT 3rd (1994) Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 35:269–272CrossRefPubMed

55.

Udd B, Krahe R, Wallgren–Pettersson C, Falck B, Kalimo H (1997) Proximal myotonic dystrophy––a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromusc Disord 7:217–228CrossRefPubMed

56.

Van Laere K, Versijpt J, Audenaert K, Koole M, Goethals I, Achten E, Dierckx R (2001) 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med 28:873–887CrossRefPubMed

57.

Van Laere KJ, Dierckx RA (2001) Brain perfusion SPECT: age- and sex-related effects correlated with voxel-based morphometric findings in healthy adults. Radiology 221:810–817CrossRefPubMed

58.

Vielhaber S, Jakubiczka S, Gaul C, Schoenfeld MA, Debska-Vielhaber G, Zierz S, Heinze HJ, Niessen HG, Kaufmann J (2006) Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1. Muscle Nerve 34:145–152CrossRefPubMed

59.

Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318–1322PubMed

Titel: Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
verfasst von: Vincenzo Romeo
E. Pegoraro
C. Ferrati
F. Squarzanti
G. Sorarù
A. Palmieri
P. Zucchetta
L. Antunovic
E. Bonifazi
G. Novelli
C. P. Trevisan
M. Ermani
R. Manara
C. Angelini
Publikationsdatum: 01.08.2010
Verlag: Springer-Verlag
Erschienen in: Journal of Neurology / Ausgabe 8/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5498-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2010

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial

Prospective evaluation of a post-stroke epilepsy risk scale

Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy

The value of motor response versus neuroimaging in predicting outcome post cardiac arrest: a retrospective study

Communications of the European Neurological Society

Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie